| Description | Cusatuzumab, a human αCD70 monoclonal antibody, exhibits cytotoxic activity and enhances antibody-dependent cellular cytotoxicity. It reduces leukemia stem cells (LSCs), triggers gene signatures associated with myeloid differentiation and apoptosis, and holds potential for Acute myeloid leukemia (AML) research [1]. |
| molecular weight | N/A |
| CAS | 1864871-20-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |